Oncology Drugs Global Market Estimated To Grow At 25% Rate
Oncology Drugs Market Report by The Business Research Company covers oncology drugs market size, drivers, restraints, key players, and the impact of COVID-19.
LONDON, GREATER LONDON, UK, October 13, 2022 /EINPresswire.com/ -- As per The Business Research Company's "Oncology Drugs Global Market Report 2022”, the oncology drugs market is predicted to grow from $199.95 billion in 2021 to $223.21 billion in 2022 at a compound annual growth rate (CAGR) of 11.60%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. According to the oncology drugs market forecast, the market is expected to reach $540.60 billion in 2026 at a CAGR of 24.80%.
Request A Sample Now To Gain A Better Understanding Of Oncology Drugs Market:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3616&type=smp
Key Trends In The Oncology Drugs Market
Companies in the oncology drug market are investing in targeted therapy, which has proven to be less toxic compared to traditional treatment options. Targeted cancer therapies are drugs or substances which block the growth of cancer by interfering with molecules that are more specifically involved in cancer cell progression than in normal cell activity. The goal of these therapies is to eliminate cancerous cells in the body while leaving normal cells unharmed. By focusing on changes in the cell that are specific to cancer, this therapy may prove to be more effective than traditional chemotherapy and radiotherapy. Companies in oncology market such as Pfizer, Novartis and Abbvie have understood the importance of this treatment method and are increasingly investing in it. According to a report by QuintilesIMS, 87% of the drugs currently in pipeline constitute of targeted therapy drugs.
Overview Of The Oncology Drugs Market
The oncology drugs global market consists of sales of oncology drugs and related services by entities (organizations, sole traders and partnerships) that produce oncology drugs to diagnose and treat all types of cancers. This industry includes establishments that produce drugs used in chemotherapy, surgery and radio therapies for treating pancreatic cancer, breast cancer, ovarian cancer, brain tumor, and other different cancer types.
Learn More On The Global Oncology Drugs Market Report At:
https://www.thebusinessresearchcompany.com/report/oncology-drugs-global-market-report
Oncology Drugs Global Market Report 2022 from TBRC covers the following information:
Market Size Data
Forecast period: Historical and Future
By region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
By countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Market Segmentation
By Type: Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs, Colorectal Cancer Drugs, Gastric Cancer Drugs, Kidney Cancer Drugs, Brain Tumor Drugs, Thyroid Cancer Drugs, Skin Cancer Drugs, Bladder Cancer Drugs, Cervical Cancer Drugs, Blood Cancer Drugs, Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others
By Route of Administration: Oral, Parenteral, Others
By Drug Classification: Branded Drugs, Generic Drugs
By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs
By Geography: The global oncology drugs market segmentation is divided into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America holds the largest share in the market.
Major market players such as F. Hoffmann-La Roche Ltd, Novartis AG, Gilead Sciences Inc, Bayer AG, and Takeda Pharmaceticals.
Trends, Opportunities, Strategies And So Much More.
Oncology Drugs Global Market Report 2022 is one of The Business Research Company’s comprehensive reports that provides an overview of oncology drugs market. The market report analyzes oncology drugs market size, oncology drugs market growth drivers, oncology drugs market segments, oncology drugs market major players, oncology drugs market growth across geographies, and oncology drugs global market competitors’ revenues and market positioning. The oncology drugs global market report enables you to gain insights on opportunities and strategies, as well as identify countries and segments with the highest growth potential.
Not What You Were Looking For? Go Through Similar Reports By The Business Research Company:
Lung Cancer Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report
Oncology Biosimilars Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report
Oncology Molecular Diagnostics Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report
About The Business Research Company?
The Business Research Company has published over 3000 industry reports, covering over 3000 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Check out our:
LinkedIn: https://bit.ly/3b7850r
Twitter: https://bit.ly/3b1rmjS
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Market Research Products, Services, Solutions For Your Business - TBRC
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
